related documents
- Cost Effectiveness of Ticagrelor plus Aspirin vs. Aspirin Alone in Acute Stroke or Transient Ischemic Attack: an Economic Evaluation of the THALES Trial. Conference Paper
- Health-related Quality of Life within 90 Days after Acute Ischemic Stroke or Transient Ischemic attack: Data from the SOCRATES Trial Abstract
- Healthcare resource utilization after subsequent stroke in patients with acute ischemic stroke or transient ischemic attack: data from the SOCRATES trial Abstract
- Ischemic Benefit and Hemorrhagic Risk of Ticagrelor-Aspirin vs. Aspirin in Patients with Acute Ischemic Stroke or TIA Conference Paper
- Ticagrelor and asprin versus aspirin along in acute ischemic stroke and TI: Results of the THALES trial Conference Paper